Search

Search Constraints

You searched for: Author/Creator Zemla, Tyler

Search Results

1. Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groups. Issue 8 (18th December 2018)

2. Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial. (28th November 2019)

3. Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622). Issue 5 (September 2018)

4. Extending venous thromboembolism secondary prevention with apixaban in cancer patients: The EVE trial. (11th November 2019)

5. Hematology patient reported symptom screen to assess quality of life for AL amyloidosis. Issue 5 (20th March 2017)

7. Older‐Patient‐Specific Cancer Trials: A Pooled Analysis of 2, 277 Patients (A151715). (12th April 2019)

8. Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance). Issue 2 (9th August 2022)

9. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial. (April 2019)

10. PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68Ga‐PSMA‐11 PET Using Cyclotron‐Produced 68Ga. Issue 5 (15th November 2021)